Are Specialty Drugs ‘Non-Essential?’ The Argument Underlying Alternative Funding Programs

image of tree focused on intricate roots
Health plans contention that specialty drugs aren't an essential health benefit is a root issue underlying new insurance designs. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet